Fluorescence In Situ Hybridization on DNA Halo Preparations to Reveal Whole Chromosomes, Telomeres and Gene Loci
March 4th, 2021
4.6K views
Combining DNA halo preparations with fluorescence in situ hybridization enables high-resolution analysis of genomic interactions with the nucleoskeleton. Attached genome leads to hybridized fluorescent signals located within the residual extracted nuclei, whereas non-attached genome is in the halo of DNA surrounding the residual nuclei.
Overview
This study presents a protocol combining DNA halo preparations with fluorescence in situ hybridization to analyze genomic interactions with the nucleoskeleton at high resolution. The method facilitates the discrimination between attached and non-attached genome structures in treated cancer and progeria cells, illustrating potential applications across various cell and tissue types.
Key Study Components
Research Area
- Genomic interactions
- Nucleoskeleton analysis
- Single-cell assays
Background
- Assesses nucleoskeleton attachments compared to DamID sequencing.
- Highlights functional gene and chromosome differences.
- Applicable across the lifespan and various diseases.
Methods Used
- Fluorescence in situ hybridization
- DNA halo preparations
- Microscopy and imaging techniques
Main Results
- Visualized chromosome territories and telomere distribution in DNA halos.
- Identified differences in chromosome attachment between control and diseased cells.
- Validated effectiveness of the method for analyzing genomic structures.
Conclusions
- The study demonstrates a cost-effective way to explore genomic organization.
- It provides relevant insights for future research into cancer and age-related cellular changes.
Frequently Asked Questions
What is the main advantage of this protocol?
It is cost-effective and provides high-resolution insights into genomic interactions.
Can this method be applied to various cell types?
Yes, it can be used across different cell and tissue types.
What technologies are utilized in this study?
Fluorescence in situ hybridization and microscopy techniques are employed.
How does this method compare to DamID sequencing?
This protocol assesses nucleoskeleton attachments directly at the single-cell level.
What biological effects does this method highlight?
It reveals functional differences between chromosomes and provides insights into cellular aging.
What specific conditions were tested?
The method was tested on treated cancer and progeria cells.
How are telomeres visualized in this study?
Telomeres are marked and quantified within DNA halos using fluorescent probes.
Executive Industry Relevance
HALO-FISH enables high-resolution visualization of genome-nucleoskeleton interactions, supporting target validation by revealing chromosomal and telomeric organization in disease models. This single-cell, cost-effective approach enhances predictive confidence in preclinical models by linking genomic architecture to functional phenotypes in cancer and progeria.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses by visualizing chromosome territories and telomere positioning relative to nuclear structures.
- Operational Value: Enables functional target validation through direct observation of genomic attachments in single cells.
- Predictive Value: Supports mechanistic de-risking by identifying attachment differences in diseased versus control cells.
Screening & Assay Development
- Assay Readiness: Produces reproducible DNA halo preparations suitable for standardized FISH-based screening.
- Quantitative Output: Enables measurement of telomere and gene locus distribution within halos for comparative analysis.
- Scalability: Compatible with various cell types and model organisms where probes are available.
Translational & Preclinical Research
- Disease Relevance: Applied to cancer and Hutchinson-Gilford progeria cells to detect genomic behavioral differences.
- Translational Continuity: Bridges discovery and preclinical work by linking nuclear organization to cellular aging and disease progression.
- Risk-Adjusted Decisions: Highlights attachment variations that inform target confidence and pathway validation.
Pipeline & Workflow Integration
The method fits within early discovery to preclinical workflows, providing structural insights that complement functional assays in target validation and lead identification stages.
- Discovery Biology: Supports hypothesis testing by revealing spatial genome organization unattainable with standard FISH.
- Screening: Delivers standardized, quantitative imaging outputs for compound or genetic condition comparisons.
- Analytics: Generates measurable readouts such as telomere percentage and chromosome territory positioning.
- Translational Research: Connects nuclear architecture findings to preclinical models of aging and oncogenesis.
- Enterprise Reuse: Establishes a reusable platform for nucleoskeleton-associated genomic studies across projects.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence by reducing ambiguity in genomic structure-function relationships.
- Operational Value: Offers a cost-effective, accessible alternative to sequencing-based nucleoskeleton mapping.
- Strategic Value: Improves go/no-go decisions through direct visualization of chromosomal alterations in disease models.
- Portfolio Impact: Enables risk-adjusted prioritization of targets based on nuclear organization phenotypes.
Implementation Considerations
- Requires expertise in fluorescence microscopy and FISH probe handling.
- Dependent on access to autoclave, hybridization chambers, and epifluorescence microscopes.
- Needs standardization of cell seeding density and extraction timing for reproducible halo formation.
- Adaptable to various cell types, but probe availability limits target scope.
- Limited by the need for optimized denaturation and hybridization conditions to prevent nonspecific binding.
Biopharma FAQs
Why does chromosome attachment analysis matter for target validation?
Chromosome attachment to the nucleoskeleton reflects functional genome organization, and alterations in attachment—such as those seen in progeria and cancer cells—can indicate disrupted regulatory mechanisms. Detecting these changes via HALO-FISH supports target validation by linking nuclear structure to disease phenotype. This enables mechanistic de-risking before advancing targets into preclinical programs.
How does isolating the DNA halo improve independent variable control in genomic studies?
The DNA halo preparation extracts soluble nuclear proteins and unattached DNA, isolating the fraction of genome tightly bound to internal nuclear structures. This isolation allows researchers to study attached chromatin as a defined independent variable, minimizing background from diffusible nuclear components. By controlling this variable, HALO-FISH increases reproducibility in comparing genomic organization across conditions.
What quantitative measurements does telomere distribution in DNA halos enable?
HALO-FISH allows quantification of telomere localization within the halo versus the residual nucleus, expressed as a percentage of total telomeric signal. In the study, the mean telomere percentage in the halo was approximately 17% in quiescent cells, providing a measurable baseline for comparison. Such quantitative outputs enable objective assessment of telomere positioning changes in response to genetic or environmental perturbations.
Why are replication requirements important for HALO-FISH in cross-functional collaboration?
Replication ensures that observed differences in chromosome or telomere positioning are not due to technical variability in halo preparation or probe hybridization. Consistent results across replicates build confidence in the method’s reliability for multi-site or cross-team studies. This reproducibility is essential for aligning discovery, screening, and translational teams around shared genomic architecture data.
What statistical analysis is needed before implementing HALO-FISH in a discovery pipeline?
Before implementation, teams should establish statistical thresholds for significant differences in chromosome attachment or telomere distribution, as demonstrated by the statistically significant changes in chromosomes 1 and 13 between control and diseased cells. Analysis should include comparative quantification across conditions with appropriate replicates to detect biologically meaningful shifts. This ensures that observed genomic changes are robust and actionable for target prioritization.
